Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

2965

Actual shortage: 237 (8%)
Anticipated shortage: 27 (1%)
Avoided shortage: 9 (0%)
Resolved: 2692 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

25 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2017-08-24 2017-09-22 20281
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2018-01-18 2018-02-12 36432
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2018-03-13 2018-07-03 42717
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2020-04-13 2020-05-22 111901
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2020-05-08 2020-05-22 114285
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2020-06-04 2020-07-28 116533
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2020-08-06 2020-11-28 121891
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2023-09-07 2023-09-15 203819
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-10 245
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-17 249
APO-RIZATRIPTAN RPD 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-11 2020-07-06 490
APO-RIZATRIPTAN RPD 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-11 2018-09-11 493
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-06-13 2017-07-31 12689
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-08-08 2017-08-23 18546
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-03 2018-01-29 24277
APO-ZOLMITRIPTAN RAPID 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-12 2018-09-12 25649
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-13 2018-08-15 29036
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-15 2018-01-31 29348
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-02 2018-09-04 44507
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-02 2018-08-15 44510

Showing 1 to 20 of 2965

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ATORVASTATIN 20MG TABLET Discontinued 2018-09-07 2019-02-13 60279
APO-ATORVASTATIN 40MG TABLET Discontinued 2018-09-07 2018-11-09 60282
APO-ATORVASTATIN 80MG TABLET Discontinued 2018-09-07 2018-12-29 60285
APO-BOSENTAN 125.0MG TABLET Discontinued 2018-09-07 2018-10-31 60291
APO-BROMAZEPAM 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304
APO-BROMAZEPAM 3MG TABLET Discontinued 2018-09-07 2019-06-12 60307
APO-BROMAZEPAM 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60313
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60316
APO-CANDESARTAN 4MG TABLET Discontinued 2018-09-07 2018-09-15 60319
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-CANDESARTAN 32MG TABLET Discontinued 2018-09-07 2018-09-15 60328
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60331
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60335
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CEPHALEX 250MG TABLET Discontinued 2018-09-07 2019-02-21 60370
APO-CILAZAPRIL 1MG TABLET To be discontinued 2018-09-07 2018-12-28 60373
APO-CIPROFLOX 250MG TABLET Discontinued 2018-09-07 2018-09-15 60379
APO-CIPROFLOX 500MG TABLET Discontinued 2018-09-07 2018-09-15 60382

Showing 81 to 100 of 356